The Selection Study

The Selection Study

Information About This Study:

Combined Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Ulcerative Colitis.

Study Number:

GS-US-418-3898

Indication:

Ulcerative Colitis

Open to Volunteers

More information can be found at:  https://www.clinicaltrials.gov/ . ClinicalTrials.gov is a registry of clinical trials run by the United States National Library of Medicine at the National Institutes of Health.